- Home
- KPTI vs PNST Comparison
KPTI vs PNST Comparison
Compare KPTI & PNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- PNST
- Stock Information
- Founded
- KPTI 2008
- PNST 2007
- Country
- KPTI United States
- PNST United States
- Employees
- KPTI N/A
- PNST N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- PNST Blank Checks
- Sector
- KPTI Health Care
- PNST Finance
- Exchange
- KPTI Nasdaq
- PNST Nasdaq
- Market Cap
- KPTI 121.2M
- PNST 111.5M
- IPO Year
- KPTI 2013
- PNST N/A
- Fundamental
- Price
- KPTI $0.89
- PNST $0.67
- Analyst Decision
- KPTI Strong Buy
- PNST Strong Buy
- Analyst Count
- KPTI 4
- PNST 3
- Target Price
- KPTI $5.00
- PNST $4.50
- AVG Volume (30 Days)
- KPTI 864.9K
- PNST 64.9K
- Earning Date
- KPTI 10-31-2024
- PNST 09-04-2024
- Dividend Yield
- KPTI N/A
- PNST N/A
- EPS Growth
- KPTI N/A
- PNST N/A
- EPS
- KPTI N/A
- PNST N/A
- Revenue
- KPTI $145,668,000.00
- PNST $123,579,000.00
- Revenue This Year
- KPTI $6.41
- PNST $26.11
- Revenue Next Year
- KPTI $11.85
- PNST $19.16
- P/E Ratio
- KPTI N/A
- PNST N/A
- Revenue Growth
- KPTI N/A
- PNST 11.06
- 52 Week Low
- KPTI $0.62
- PNST $0.56
- 52 Week High
- KPTI $1.95
- PNST $16.00
- Technical
- Relative Strength Index (RSI)
- KPTI 62.92
- PNST 23.27
- Support Level
- KPTI $0.71
- PNST $0.56
- Resistance Level
- KPTI $0.94
- PNST $0.73
- Average True Range (ATR)
- KPTI 0.07
- PNST 0.13
- MACD
- KPTI 0.02
- PNST 0.01
- Stochastic Oscillator
- KPTI 78.86
- PNST 15.12
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About PNST Pinstripes Holdings Inc.
Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.